Publications
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013 and older
- Ex Officio Member: The Apollo Program for Biodefense. Winning the Race Against Biological Threats. Bipartisan Commission Report. (2021) https://biodefensecommission.org/reports/the-apollo-program-for-biodefense-winning-the-race-against-biological-threats/
- Ex Officio Member: Bipartisan Commission on Biodefense. Biodefense in Crisis: Immediate Action Required to Address National Vulnerabilities. March 2021. https://biodefensecommission.org/reports/biodefense-in-crisis-immediate-action-needed-to-address-national-vulnerabilities/
- Lennerz, J.K., Marble, H.D., Lasiter, L. et al. Do not sell regulatory science short. Nat Med (2021). https://doi.org/10.1038/s41591-021-01298-6
- tt, M., Nickerson, C., Poste, G., and Curtiss, 3rd, R. (2021). A Vision for the Next Generation of Spaceflight Microbiology: Human Health and Habitat Sustainability. Biodesign Center for Fundamental and Applied Microbiomics. [Unpublished manuscript]. Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University. https://ntrs.nasa.gov/api/citations/20210022952/downloads/OttCharlieM%20-%20ExportControl.docx.pdf
- Nickerson, C.A., Medina-Colorado, A.A., Barrila, J. et al. A vision for spaceflight microbiology to enable human health and habitat sustainability. Nat Microbiol (2021). https://doi.org/10.1038/s41564-021-01015-6
- Moses H, Matheson DHM, Poste G. Serving Individuals and Populations Within Integrated Health Systems: A Bridge Too Far? JAMA. Published online March 28, 2019. doi:10.1001/jama.2019.2929
- Domenyuk, V., Gatalica, Z., Santhanam, R., Wei, X., Stark, A., Kennedy, P., ... Spetzler, D. (2018). Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes. Nature Communications, 9(1), [1219]. https://doi.org/10.1038/s41467-018-03631-z
- Togami, E., J. L. Gardy, G. R. Hansen, G. H. Poste, D. M. Rizzo, M. E. Wilson, and J. A. K. Mazet. 2018. Core
Competencies in One Health Education: What Are We Missing? NAM Perspectives. Discussion Paper, National
Academy of Medicine, Washington, DC. https://nam.edu/core-competencies-in-one-health-education-what-are-wemissing - Blue Ribbon Study Panel on Biodefense. Budget Reform for Biodefense: Integrated Budget Needed to Increase
Return on Investment. Blue Ribbon Study Panel on Biodefense: Washington, DC. February 2018. - Holding the Line on Biodefense State, Local, Tribal, and Territorial Reinforcements Needed A Bipartisan Report of the Blue Ribbon Study Panel on Biodefense. October 2018. https://www.biodefensestudy.org/Holding-the-Line-on Biodefense
- Domenyuk, V., Zhong, Z., Stark, A., Xiao, N., O’Neill, H. A.Wei, X., Wang, J., Tinder, T. T., Tonapi, S., Duncan, J., Hornung, T., Hunter, A., Miglarese, M. R., Schorr, J., Halbert, D. D., Quackenbush, J., Poste, G., Berry, D. A., Mayer, G., Famulok, M., and Spetzler, D. (2017) “Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach” Nature Scientific Reports | 7:4274 | https://doi.org/10.1038/srep42741
- Poste, G. (2017). “The Complex Strategic Landscape for Precision Medicine: Cost, Convergence, Culture, Computing and Creative Destruction” Journal of Precision Medicine, 3, 36-51.
http://www.thejournalofprecisionmedicine.com/archive-manager/the-complex-strategic-landscape-for-precisionmedicine-cost-convergence-culture-computing-and-creative-destruction/ - Alexander, B. M., Ba, S., Berger, M. S., Berry, D. A., Cavenee, W. K., Chang, S. M., Cloughesy, T. F., Jiang, T.,
Khasraw, M., Li, W., Mittman, R., Poste, G. H., Wen, P. Y., Yung, W. K. A., and Barker, A. D. “Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE” Clinical Cancer Research 24(3) (2017) DOI: 10.1158/1078-0432.CCR-17-0764 - MacIntyre, C. R., Engells, T. E., Scotch, M., Heslop, D. J., Gumel, A. B., Poste, G., Chen. X., Herche, W., Steinhöfel, K., Lim, S., and Broom, A. “Converging and Emerging Threats to Health Security” Environment System Decisions, (2017). https://doi.org/10.1007/s10669-017-9667-0
- Hodges, T.R., Ferguson, S.D., Caruso, H.G., Kohanbash, G., Zhou, S., Cloughesy, T.F., Berger, M.S., Poste G.H., Khasraw, M., Ba, S., Jiang, T., Mikkelson, T., Yung, W. K., de Groot, J.F., Fine, H., Cantley, L.C., Mellinghoff, I.K., Mitchell, D.A., Okada, H., and Heimberger, A.B. "Prioritization Schema for Immunotherapy Clinical Trials in Glioblastoma." OncoImmunology 5, 6 (2016) DOI: 10.1080/2162402X.2016.1145332
- Member, International Ebola Vaccine Team Report. (2015) "Recommendations for Accelerating the Development of Ebola Vaccines: Report & Analysis"
- Castillo-Chavez, C., Curtiss, R., Daszak, P., Levin, S., Patterson-Lomba, O., Perrings, C., Poste, G., and Towers, S. (2015) “Beyond Ebola: Lessons to Mitigate Future Pandemics” The Lancet Global Health 3(7). 25
394. Osterholm, M., Moore, K., Ostrowsky, J., Kimball-Baker, K., Farrar, J., and Wellcome Trust-CIDRAP Ebola Vaccine Team B (Poste, G.). (2015) The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats. Lancet Infectious Diseases 16(1). (2015) (DOI: https://doi.org/10.1016/S1473-3099(15)00416-8 ) - Member, Veterans Choice Act, Blue Ribbon Panel. “Independent Assessment of the Health Care Delivery Systems and Management Processes of the Department of Veterans Affairs. Veterans Access, Choice, and Accountability Act of 2014” Section 201. Prepared by the Department of Veterans Affairs. A Product of the CMS Alliance to Modernize Healthcare Federally Funded Research and Development Center, (2015). Print. Volume I: Integrated Report. Task Order No. VA118A14F0373-384.
- Panel Ex Officio Member (2015) Bipartisan Report of the Blue Ribbon Panel on Biodefense
- Poste G., Barker A., Compton C. (2014) The National Biomarker Development Alliance (NBDA): Confronting the Poor Productivity of Biomarker Research and Development. Expert Rev. Mol. Diagn. (doi:10.1586/14737159.2015.974561)
- Barker A., Compton C., Poste G. (2014) The National Biomarker Development Alliance (NBDA): Accelerating the Translation of Biomarkers to the Clinic. Biomarkers Med. 8(6), 873–876
http://www.futuremedicine.com/doi/pdf/10.2217/bmm.14.52 - Poste, G. (2014). Precision Oncology: Big Data And Analytics Come To Cancer Care.
Life Science Leader. From http://www.lifescienceleader.com/doc/precision-oncology-big-data-and-analytics-come-to-cancer-care-0001
- G. Poste. Confronting . Biosecurity: Enhancing Security in an Increasingly Unsecure World. Guest Lecture, Biology and Society Bio 311/HPS 340; Fall 2013. Tempe, Arizona (Dec 3 2013)
- G. Poste. Confronting the Cancer Challenge: The Need for New Diagnostic and Treatment Strategies. Presentation at Clearity Foundation’s Personalized Medicine in Oncology Series. Moores Cancer Center, La Jolla, CA (Oct 8 2013)
- G. Poste. Outpacing Infectious Diseases: Dynamic Foes and The Need for Innovation in Diagnostics, Drugs and Vaccines. Presentation at ASU General Biochemistry BCH462. Tempe, Arizona (Sep 10 2013)
- George Poste Opening New Investigative Directions for GBM: Confronting Complexity. Glioblastoma Multiforme (GBM): A Think Tank to Re-Think GBM and Set a New Course.
- Montelucia Resort and Spa, Scottsdale, AZ (Aug 27 2013)
- George Poste The Acceleration, Convergence and Globalization of Advanced Technologies: Escalating Complexity, Disruptive Change and New Networked Organizations.
- Conference on Governance of Emerging Technologies: Law, Policy and Ethics. ASU Sandra Day O’Connor College of Law (May 21 2013)
- George Poste. Transformational Technologies in Biomedical R&D and Healthcare Delivery. Hever 18. Lansdowne, VA (May 4 2013)
- George Poste. Biosecurity: Enhancing Security in an Increasingly Complex World. Threat Preparation for the 21st Century: Association of University Research Parks Annual Meeting. Tempe Mission Palms, Tempe, AZ (Mar 6 2013)
- George Poste. Technology and Molecular Medicine: A Developer’s Perspective. ASU:University of Chicago Public Health Law Conference: Technology and the Rising Cost of Health Care – A Paradigm Shift. Sandra Day O’Connor College of Law, Arizona State University, Tempe, AZ (Mar 2 2013)
- George Poste. Personalized (Precision) Medicine: Science, Law and Health Policy. Keynote Address,. From Bench to Society: Law and Ethics at the Frontier of Genomic Technology. UC Hastings College of the Law, San Francisco (Feb 8 2013)
- George Poste. Overview of Complex Adaptive Systems (CAS) at Arizona State University (ASU). An Introductory Workshop – CAS at ASU. Old Main – Arizona State University (Jan 18 2013)
- George Poste. Outpacing Global Infectious Diseases(panel). An Introductory Workshop – CAS at ASU. Old Main – Arizona State University (Jan 18 2013)
- Poste, G. A Status Report on Biomarkers: biomarkers that are not; standards that are forgot; and the need to transform the system we’ve got!. National Biomarkers Development Alliance (NBDA). JW Marriott Camelback Inn, Scottsdale, Arizona (Dec 13 2012 – Dec 14 2012)
- Poste, G. Keynote Address: Computational Challenges and Opportunities in Personalized Medicine. INFORMS: Annual Meeting 2012. Phoenix Convention Center (Oct 14 2012)
- Poste, G. Biosecurity: Enhancing Security in an Increasingly Unsecure World. Guest Lecture, Biology and Society Bio 311/HPS 340; Fall 2012. LS 191 (Oct 4 2012)
- Poste, G. Keynote Presentation: Integrative Omics (iOmics) and the Evolution of Molecular Medicine. 8th Annual Burrill Personalized Medicine Meeting. San Francisco, CA (Sep 13 2012)
- Poste, G. Presentation at DHS-DOD Meeting. Policy Implications of Digital Fabrication: 3D Printing and Beyond. Schaefer Institute, Washington, DC (Jul 26 2012)
- Poste, G.. Presentation for ASLME Health Law Professors Conference. Medicine and Ethics 35th Annual Health Law Professors Conference. Tempe, AZ (Jun 8 2012)
- George Poste. Poste G. New Value Propositions in Healthcare. Burrill Meeting Cavallo Point. Beyond the Genome: Opportunities in Large Scale Sequencing. Cavallo Point Lodge, CA (Apr 17 2012)
- Buetow, K. The Next Frontier: Personalized Medicine and Cancer.. G2 Intelligence, MDx Next Spring 2012. Fairmont Copley Plaza, Boston, MA (Apr 17 2012 – Apr 19 2012)
- Poste G. Challenges and Opportunities in Molecular Diagnostics as Key Components of Molecular Medicine. Sandra Day O’Connor Law School Symposium. Scottsdale, Arizona (Apr 4 2012)
- Poste G. Challenges and Opportunities in Molecular Diagnostics as Key Components of Molecular Medicine. Sandra Day O’Connor Law School Symposium. Scottsdale, Arizona (Apr 4 2012)
- Poste, G.. A Systems Based Approach to Cancer Informatics. Institute of Medicine, National Cancer Policy Forum Workshop on “Informatics Needs and Challenges in Cancer Research”. Keck Center of the National Academies – Washington, DC (Feb 28 2012)
- Poste, G. The Evolution of Personalized Medicine: Opportunities and Challenges. ASU Office of Knowledge Enterprise Development. Pima Auditorium (Room 230) / Memorial Union – ASU Tempe Campus (Feb 21 2012)
- Poste, G. “It from Bits”: Managing Massive Data as a Critical Challenge For Biomedical R&D and Healthcare Delivery. The Burrill Biotech 24th Annual CEO Meeting. Laguna Beach, CA (Oct 17 2011 – Oct 18 2011)
- Poste, G. The Increasing Importance of the Life Sciences in National Security. FDA MCMI Lecture Series. Silver Spring, MD (Oct 6 2011)
- Poste G. “It from Bits”: Managing Massive Data as a Critical Challenge For Biomedical R&D and Healthcare Delivery. The Burrill Personalized Medicine Meeting. Burlingame, C.A. (Oct 3 2011 – Oct 4 2011)
- Poste, G. The Need for Urgent Reform in the Organization and Funding of Cancer Research and Clinical Trials. ASU-NCI Workshop. Arizona State University, Tempe, AZ (May 19 2011 – May 20 2011)
- Poste, G. The Evolution of Personalized Medicine: Opportunities and Challenges. Keynote Presentation: The Institute for Systems Biology International Symposium: Systems Biology and P4 Medicine. The Institute for Systems Biology, Seattle, WA (May 15 2011 – May 16 2011)
- Poste, G. Synthetic Biology: Mapping the Design Principles of Biological Systems and the Rise of Biomimetic Engineering. Six Academy Synthetic Biology Symposium. The Royal Society, London (Apr Buy Xanax 13 2011)
- Poste, G. Dr. Poste gave the morning keynote address on the importance and future of Synthetic Biology. Six Academy Synthetic Biology Symposium. The Royal Society, London (Apr 13 2011)
- Poste, G. Promise, Peril, Productivity and Politics:The Strategic Environment for Healthcare R&D. Burrill & Company 2011 Annual Limited Partners and Advisory Board Meeting. Park City, UT (Apr 6 2011)
- Poste, G. Biospecimens: A Critical Resource for Advances in Molecular Diagnostics, Imaging and Therapeutics. Bethesda, MD (Mar 28 2011)
- Poste, G. The Impact of the Life Sciences on National Security, Presentation at: Preserving National Security – The Growing Role of the Life Sciences. UPMC Center for Biosecurity. Washington, D.C. (Mar 3 2011)
- Poste G. Innovation Demands Boldness: Meeting Global Challenges of Escalating Complexity. The Wiseguise Luncheon Discussion Group. Scottsdale, Arizona (Jan 28 2011)
- Poste, G. The Evolution of Personalized Medicine: Opportunities and Challenges. ASU College of Nursing and Health Innovation. (Jan 14 2011)
- Poste, G. The Evolution of Personalized Medicine: Opportunities and Challenges. 27th Montreux Symposium on LC/MS. Montreux, Switzerland (Nov 10 2010)
- Poste, G. Genomics, Demographics, Epidemics, Economics and Ethics: The Complex Forces Shaping Healthcare. First Constantin Spiegelfeld Lecture. Research Center for Molecular Medicine Austrian Academy of Sciences, Vienna (Nov 8 2010)
- Dyer, J. Robots and Innovation. Innovation Demands Boldness Workshop. Westin Kierland Resort Hotel, Scottsdale, Arizona (Sep 30 2010)
- Poste, G. Innovation Demands Boldness: Meeting the Challenges of Escalating Complexity. Innovation Demands Boldness Workshop. Westin Kierland Resort Hotel, Scottsdale, Arizona (Sep 29 2010)
- Agenda. Innovation Demands Boldness Workshop. Scottsdale (Sep 29 2010 – Sep 30 2010)
- Poste, G. Sustaining Healthcare Innovation in an Era of Constraint. The 6th Annual Burrill Personalized Medicine Meeting. Burlingame, CA (Sep 27 2010)
- Poste, G. m.Health: The Emergence of a New Ecosystem for Healthcare Delivery, Global Public Health and National Security. World Economic Event on Mobile Health (mHealth). La Jolla, CA (Jun 28 2010)
- Poste, G. Bugs, Bits and Engineering Bioforms: Good and Bad Applications and Actors. New America Foundation Symposium: Warring Futures: Transforming Today’s Military. The Army and Navy Club, Washington, DC (May 24 2010)
- Poste, G. Challenges and Opportunities in Cancer Detection and Diagnosis: The Need for Systems-Based Approaches For Successful Validation of Biomarkers. NCI Cancer Early Detection Stakeholders Meeting. Rockville (May 21 2010)
- Poste, G. Sustaining Healthcare Innovation in an Era of Constraint. Gold Laboratory: Somalogic Symposium. Boulder, Colorado (May 14 2010)
- Poste, G. The Need to Build Holistic, Personalized Healthcare Delivery Systems. Poste, G. Vision 2020: The Need to Build Holistic, Personalized Healthcare Delivery Systems. International Health Forum. Munich (May 7 2010)
- Poste, G. The Convergence of Clinical Medicine, Engineering and Computing: New Horizons in Healthcare Delivery. The John F. Wilkinson Memorial Lecture. Manchester Medical Society, UK (May 5 2010)
- van der Leeuw, S. Launch of the Consortium for Biosocial Complex Systems, Interdisciplinary Science and Technology Building 1. Arizona State University, Tempe, AZ (Apr 21 2010)
- Poste, G. Technology Acceleration and Convergence: The Evolution of Novel Platforms for Improved Healthcare Delivery. Burrill LP & Advisory Board Meeting. Cavallo Point, California (Apr 20 2010)
- Poste, G. Poste, G. The Rapidly Changing International Landscape for Advanced Research Technologies: Implications for Law Enforcement, National Security and Industrial Espionage. Keynote Presentation at The FBI Campus Liaison Initiative Conference. Arizona State University, Tempe, AZ (Mar 17 2010)
- Poste, G. Addressing Technological Challenges and the Development of New Cancer Interventions. NCI Conference. Rethinking the Role of Infectious Agents in Cancer. Pentagon City, VA (Mar 16 2010)
- Poste, G. Personalized Medicine: Building the Integrated Technology Platforms for Rational Therapy, Risk Reduction and Improved Healthcare Delivery. Keynote Address at The Personalized Medicine Clinic: Policy, Legal and Ethical Implication. Biltmore Hotel, Phoenix, AZ (Mar 9 2010)
- Poste, G. Biosecurity: Enhancing Security in an Unsecure World. Biochem 20/20 Conference. The Biodesign Institute, Arizona State University, Tempe, AZ (Feb 24 2010)
- Poste, G. The Way Ahead. The National Cancer Institute – ASU Beyond Center Cancer Forum. Arizona State University, Tempe, AZ (Feb 12 2010)
- Poste, G. Technology Acceleration and Convergence: Implications for National Security and Military Affairs. CETMONS: Military Operations, and National Security. Carefree Resort, AZ (Feb 5 2010)
- Poste, G. Health Technology Acceleration and Convergence: Implications for Personalized Medicine. Keynote Address at 5th Annual Burrill Personalized Medicine Meeting. UCSF Mission Bay Conference Center, San Francisco, CA (Nov 9 2009)
- Poste, G. The Challenge of Global Preparedness For Outpacing Infectious and Parasitic Diseases Keynote. Presentation at Royal Veterinary College Symposium: Who Owns Disease?. Royal Veterinary College (RVC), UK (Sep 18 2009)
- Poste, G. The US Healthcare System: Unavoidable Realities, Harsh Truths and Stark Choices. Presentation at the Blue Cross Blue Shield: Internal Operations Conference. Ritz Carlton, Laguna Niguel, CA (Jul 20 2009)
- Poste, G. Technology Acceleration and Technology Convergence: Where Is It Taking Us?. Burrill & Company Event LP and Advisory Board Meeting. Cavallo Point Lodge, Sausalito, CA (Apr 28 2009)
- Poste, G. Research, Regulation, Risk and Reward: The Strategic Environment for Pharmaceutical R&D. Plenary Opening and Keynote Address at The Dutch Top institute Pharma Spring Meeting. Utrecht, The Netherlands (Apr 23 2009)
- Poste, G. Biotechnology, Molecular Medicine and the Future Evolution of Healthcare. Keynote Address: Invest NorthWest Conference. Seattle, WA (Mar 17 2009)
- Poste, G. On the Road to Personalized Medicine: Adoption Paths for Molecular Diagnostics and Molecular Imaging. Molecular Summit 2009: In Vivo and In Vitro Integration. Philadelphia, PA (Feb 10 2009)
- Poste, G. Biotechnology, Molecular Medicine and the Future Evolution of Healthcare Biotechnology Entrepreneur Lecture Series. Northeastern University, Boston, MA (Sep 25 2008)
- Poste, G. Building Interdisciplinary Research Excellence for Innovative Solutions to Global Challenges President’s Council of Advisors on Science and Technology Visit. The Biodesign Institute, Arizona State University, Tempe, AZ (Aug 25 2008)
- Poste, G. Building Interdisciplinary Research Excellence for Innovative Solutions to Global Challenges. The State of the Institute Review. Arizona State University, Tempe, AZ (Jul 14 2008)
- Poste, G. Innovation In Healthcare Delivery – Unavoidable Realities and Stark Choices: Future Challenges and Opportunities. Keynote Address, ILSI – Biomed Israel 2008. Tel Aviv, Israel (May 28 2008)
- Poste, G. Diagnostic Biomarkers and the Human Protein-Drug Interaction Network: Implications and Opportunities for Targeted Oncology Therapies. SAIC-Frederick, Inc. / NCI. Frederick, MD (May 1 2008)
- Poste, G. Keynote Address, Innovations In The US Healthcare System: Unavoidable Realities, Harsh Truths and Stark Choices. Blue Cross Blue Shield Broker’s Health Care Conference. Enchantment Resort, Sedona, AZ (Apr 18 2008)
- Poste, G. Synthetic Biology and Sustainability. Presentation at 1st Interdisciplinary Symposium: Global Sustainability – A Nobel Cause. Potsdam, FDR (Oct 10 2007)
- Poste, G. Protecting Security in an Unsecure World: New Threats, New Technologies and New Opportunities. Keynote Address, 60th Anniversary of the Central Intelligence Agency. Washington, D.C. (Sep 27 2007)
- Poste, G. Overview: Converging, Combining, Emerging. Highlands Forum 32,. Arizona (May 29 2007)